Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.75
1.5973.61%
At close: -
$3.62
-0.13-3.48%
After Hours: 6:46 PM EDT
Comments
Loading...
BioXcel Therapeutics Stock Price, Quotes and Forecasts
BTAINASDAQ
BioXcel Therapeutics (BTAI) Forecast
NewsEarningsBioXcel Therapeutics (BTAI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
BioXcel Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:BTAI | Benzinga
Explore BioXcel Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BTAI.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioXcel Therapeutics (BTAI) stock?
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Who are BioXcel Therapeutics (BTAI) competitors?
Other companies in BioXcel Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Portage Biotech (NASDAQ:PRTG) and Ensysce Biosciences (NASDAQ:ENSC).
What is the forecast, or price target, for BioXcel Therapeutics (BTAI) stock?
BioXcel Therapeutics has a consensus price target of $5.61.
What is the current price for BioXcel Therapeutics (BTAI)?
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $3.6195 last updated March 3, 2025 at 6:46 PM EST.
Does BioXcel Therapeutics (BTAI) pay a dividend?
There are no upcoming dividends for BioXcel Therapeutics.
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is BioXcel Therapeutics (BTAI) going to split?
There is no upcoming split for BioXcel Therapeutics.
What sector and industry does BioXcel Therapeutics (BTAI) operate in?
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.